Showing results (1871-1880 of 6,517) with videos related to

Sort By:
Pageof 652
Cancer Immunology, Immunotherapy : CII|January 1, 1986
WEHI 164 sarcoma cells rendered resistant to monocyte-released cytotoxin are also resistant to monocyte-induced cytolysisO Kildahl-Andersen, R Austgulen, J Nissen-Meyer
Cancer Immunology, Immunotherapy : CII|October 31, 2022
Lymphodepleting chemotherapy practices and effect on safety and efficacy outcomes in patients with solid tumours undergoing T cell receptor-engineered T cell (TCR-T) Therapy: a systematic review and meta-analysisKathryn Owen, Ramy Ghaly, Kyrillus S Shohdy, et al.
Cancer Immunology, Immunotherapy : CII|October 29, 2022
Comprehensive analysis of the immunological implication and prognostic value of CXCR4 in non-small cell lung cancerWei Guo, Qilin Huai, Bolun Zhou, et al.
Cancer Immunology, Immunotherapy : CII|October 4, 2022
Detecting monocyte trafficking in an animal model of glioblastoma using R2* and quantitative susceptibility mappingRunze Yang, A Max Hamilton, Hongfu Sun, et al.
Cancer Immunology, Immunotherapy : CII|September 6, 2022
Intratumoral pro-oxidants promote cancer immunotherapy by recruiting and reprogramming neutrophils to eliminate tumorsStephen John Ralph, Maxwell J Reynolds
Cancer Immunology, Immunotherapy : CII|September 1, 2022
Compromised activity of natural killer cells in diffuse large b-cell lymphoma is related to lymphoma-induced modification of their surface receptor expressionTehila Azoulay, Ilana Slouzky, Michal Karmona, et al.
Cancer Immunology, Immunotherapy : CII|February 24, 2021
Sarcopenia and the risk of adverse events in patients treated with immune checkpoint inhibitors: a systematic reviewYuli Guzman-Prado, Jennifer Ben Shimol, Ondrej Samson
Cancer Immunology, Immunotherapy : CII|September 27, 2022
Dominant-negative transforming growth factor-β receptor-armoured mesothelin-targeted chimeric antigen receptor T cells slow tumour growth in a mouse model of ovarian cancerKe Li, Jing Xu, Jing Wang, et al.
Cancer Immunology, Immunotherapy : CII|January 1, 1987
Evidence for the role of natural immunity in the control of metastatic spread of head and neck cancerS P Schantz, B W Brown, E Lira, et al.
Cancer Immunology, Immunotherapy : CII|June 7, 2011
An ADP ribosylation factor-GTPase activating protein negatively regulates the production of proinflammatory mediators in response to lipopolysaccharideAbedul Haque, Abu Shadat Mohammod Noman, Naoki Koide, et al.
Pageof 652